
The Oncotype 21-gene breast recurrence score is a validated predictive biomarker for chemotherapy benefit in ER-positive/HER2-negative breast cancer across various ethnic groups.


coremsg

A recent study validated the predictive biomarker&#039;s effectiveness in guiding treatment decisions for diverse groups.

Study Validates Breast Recurrence Score Across Ethnic Groups

validation-of-breast-recurrence-score-in-different-ethnic-groups


Validation of Breast Recurrence Score in Different Ethnic Groups
